Dr Melvin Sanicas ✓

@Vaccinologist · Switzerland · joined 19 Jul 2017

Physician-scientist MD, MSc, MBA #FIDSA #FRSPH #FRSA #FAcadMEd #TOYM Science & Medicine '21 #PAFIOO #PresidentialAward '24 Sharing insights on #GlobalHealth

34 775Followers

1 946Following

10 442Posts total

12.4KViews on collected posts

Neueste Beiträge

Dr Melvin Sanicas ✓@Vaccinologist16 Sep

#Dengue is continuing to expand beyond its traditional tropical range, with locally acquired transmission increasingly reported in the US, including #Florida. The spread of #Aedesaegypti highlights the combined effects of #climate #urbanization + #travel. https://t.co/sG0BJOd5AZ

855 views · 7 likes · 3 reposts · 0 replies Open on X →

Dr Melvin Sanicas ✓@Vaccinologist15 Sep

New @IcahnMountSinai study shows that a small subset of #pancreaticcancer cells can create fibrin-rich immune-protective niches via PAI1/PAI2, recruiting suppressive macrophages & excluding #Tcells - a new angle for pancreatic #cancer #immunotherapy https://t.co/1mBjoRk2nH https:

350 views · 4 likes · 2 reposts · 0 replies Open on X →

Dr Melvin Sanicas ✓@Vaccinologist15 Sep

Real-world data on #nirsevimab #Beyfortus: 79% effectiveness against #RSV hospitalization, 97% against ICU admission in infants. Severe RSV was seen largely in otherwise healthy babies, supporting broad prevention rather than risk-based targeting alone. https://t.co/WuO5IFZWHY ht

505 views · 6 likes · 1 reposts · 0 replies Open on X →

Dr Melvin Sanicas ✓@Vaccinologist14 Sep

#mpox remains an active and evolving global #publichealth challenge. Transmission is persisting in multiple regions, clade Ib #MPXV is expanding beyond its earlier geographic concentration, Africa continues to bear the greatest burden - latest from @WHO https://t.co/i1TP4uxYA7 ht

319 views · 50 likes · 1 reposts · 0 replies Open on X →

Dr Melvin Sanicas ✓@Vaccinologist10 Aug

Grateful to the @LSHTM for recognizing my election as a Fellow of the @IDSAInfo Infectious Diseases Society of America #FIDSA. I completed my MSc in Infectious Diseases at the #LSHTM so this recognition is especially meaningful. https://t.co/DwkDNmChTC https://t.co/Ns400rzv9n

10.4K views · 64 likes · 1 reposts · 0 replies Open on X →

Im Vergleich zu Konten gleicher Größe

5 Beiträge aus den letzten 90 Tagen, verglichen mit der Größenklasse 10K–100K Follower. erreicht weniger Menschen als Konten gleicher Größe.

Medianaufrufe505dieses Konto972Median für 10K–100K

Reichweite, %1.45%dieses Konto3.58%Median für 10K–100K

Interaktion, %1.58%dieses Konto1.60%Median für 10K–100K

Kennzahl	Dieses Konto	Median für 10K–100K	Verhältnis
Medianaufrufe pro Beitrag	505	972	0.52×
Reichweite (Aufrufe ÷ Follower)	1.45%	3.58%	0.41×
Interaktionsrate	1.58%	1.60%	0.99×

Weitere Konten dieser Größe → Mit einem anderen Konto vergleichen → Wie diese Vergleichswerte entstehen →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

10.4K10 Aug

31914 Sep

50515 Sep

350

85516 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.63%10 Aug

16.30%14 Sep

1.58%15 Sep

2.00%

1.29%16 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.60%.

What the audience does

Likes89.7%131 in total

Reposts5.5%8 in total

Quotes2.7%4 in total

Bookmarks2.1%3 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.